8th Annual Pharma Anti-Counterfeiting & Serialisation 2020
Share
Now
WHY SHOULD YOU ATTEND?
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
Event Speakers
PINGPING NI
AstraZeneca
JEREMY PETERS
Bristol-Myers Squibb (USA)
SULTAN DAJANI
Wainwrights Chemists
SIDDHI TRIVEDI
Beyond Identity
BILL ARONSON
Artificial Intelligence Research Group
BILL ARONSON
Artificial Intelligence Research Group
BILL ARONSON, COO, Artificial Intelligence Research Group
EIKE HILLBRICHT
Boehringer Ingelheim
EIKE HILLBRICHT
Boehringer Ingelheim
EIKE HILLBRICHT, Corporate Security Manager, Boehringer Ingelheim
MATTHEW COPE
Intellectual Property Office
MATTHEW COPE
Intellectual Property Office
MATTHEW COPE, Deputy Director, IP Enforcement, Intellectual Property Office
HUSSAIN A M
GABOR PURMAN
NexGen Healthcare Communications
GABOR PURMAN
NexGen Healthcare Communications
GABOR PURMAN, Scientific Solutions Director, NexGen Healthcare Communications
GARY JOHNSTON
Bayer
SEBASTIEN M
Ferring Pharmaceuticals
SEBASTIEN M
Ferring Pharmaceuticals
SEBASTIEN MAUEL, Director of the Serialization Program, Ferring Pharmaceuticals
HARIPRASAD R
Google Cloud
EVI MATHIOU
Novo Nordisk
EVI MATHIOU
Novo Nordisk
EVI MATHIOU, Legal, Compliance & Quality Manager BA Europe East & South, Novo Nordisk
STAN SHEPHERD
Instant Access Medical
ADRIAN V D H
EMVO
ADRIAN V D H
EMVO
ADRIAN VAN DEN HOVEN, Director General, Medicines for Europe (President Of The Board Of Directors, European Medicines Verification Organisation (EMVO)
EDDIE GUZDAR
Sanofi Genzy
MARCEL D G
Abbott
MARCEL D G
Abbott
MARCEL DE GRUTTER, Project Manager Serialization - Regulatory & Government Affairs Liaison, Abbott
PATRIK MERCKELL
Roche
PATRIK MERCKELL
Roche
PATRIK MERCKELL, External Business Process Analyst and Project Manager, Roche (Founder, accent.world sa)
MYLES FURNACE
Ipsen
MYLES FURNACE
Ipsen
MYLES FURNACE, Digital Health and Data Lead, UK & Ireland Speciality Care, Ipsen
MIKE ISLES
EAASM
“Competences to Combat Counterfeits & impact of AI, IoT, Blockchain & Big Data in Pharma ”
Event Schedule
Meet and to network with your conference colleagues.
08:30 – Coffee and registration
09:30 - Chairperson opening remarks
BILL ARONSON, COO, Artificial Intelligence Research Group
MARKET ANALYSIS & CURRENT OVERVIEW
09:40 – Illicit Online Pharmacies & Dark Net Counterfeiting operations
NICHOLAS CALL, Special Agent, FDA
10:20 – EMVO - 1 year after implementation
ADRIAN VAN DEN HOVEN, Director General, Medicines for Europe (President Of The Board Of Directors, European Medicines Verification Organisation (EMVO)
11:00 – Morning Coffee & Networking
CHALLENGES & OPPORTUNITIES
11:30 – Morning Keynote Panel Discussion: – Challenges and Opportunities – Breaking the barriers toutilize the opportunities
• Post (FMD) Deadline – How are we doing? What else needs to be done?
• Combatting counterfeiting, and overcoming the coordination challenges
• Market analysis – EU, US and RoW markets
• Impact of BREXIT
• FMD compliance to be included in GPhC pharmacy inspections
• Strategies and solutions to optimize your information storing and sharing, and quality management
• Future of automation, data and process standardization supports the future of anti-counterfeiting efforts and product integrity
• Next-generation anti-counterfeiting – How to prepare for it? What should be done?
Moderator
BILL ARONSON, COO, Artificial Intelligence Research Group
Panellists
ADRIAN VAN DEN HOVEN, Director General, Medicines for Europe (President Of The Board Of Directors, European Medicines Verification Organisation (EMVO)
NEIL LAWRENCE, Global Serialisation Champion, GSK
ERIK MEZACK, Global Serialization Technical Lead, Teva
JACK JING, Global Business Development Director / Head of EU Commercial Operations, Seacross Pharmaceuticals
12:10 – Serialization – The next wave
• From Compliance to Optimization – Serialization 2.0
• Deployment stories
• Overview ARC
• About Advanco
Sami Bilal, Director Product Management, Advanco
12:30 – Networking luncheon / Exhibition Visit
INTELLECTUAL PROPERTY PROTECTION
13:30 – E-Commerce: connecting an unconnected Internet ecosystem
• The rising tide of fake pharmacy websites
• How the Internet stakeholders need to become more connected
• There is no silver bullet just lots of small rounds – what needs to be done
• Stemming public demand by raising awareness is key
MIKE ISLES, Executive Director, European Alliance for Access to Safe Medicines
14:00 - Anti-Counterfeiting Investigations from industry perspective
• The Global issue
• Why do companies need an ACF strategy
• Investigative methods
• Collaboration
• Case study
GARY JOHNSTON, Global Security – Product Crime Investigations, Bayer
14:30 – Digital transformation and anti-counterfeiting strategy
• What will change? What do we need in terms of health?
• Tracking, tracking, tracking
• How to adapt the anti-counterfeiting strategy to the new situation
• How to set up a regulatory oversight committee
• Case study Pharma Industry and Supply Chain 4.0
PATRIK MERCKELL, External Business Process Analyst and Project Manager, Roche (Founder, accent.world sa)
15:00 – Afternoon coffee & Networking
FIGHTING FAKES – BRAND PROTECTION
15:20 – Counteracting Counterfeiting
• Medicines are not ordinary items of commerce and why faking them is like playing Russian Roulette
• The risks of not implementing measures to public health
• Measures being taken in the UK
• Latest updates since implementation
SULTAN DAJANI, Pharmacist Superintendent, Wainwrights Chemists
15:50 - Serialisation, the past the present and the future
• How did Serialisation legislation originate
• How have industry delivered and what have been the challenges
• What is the next steps for the technology
NEIL LAWRENCE, Global Serialisation Champion, GSK
PHARMACY PERSPECTIVE
16:20 – Pharmacy perspective – Last part of supply chain
• Final part in supply chain before medication reaches patients
• Safe packaging
• Packaging has led to patient safety incidents and dispensing errors, and FMD
LEYLA HANNBECK, CEO, Association of Independent Multiple Pharmacies
16:50 - Chairperson’s closing remarks and end of conference
16:50 – 18:00 – Networking Drinks - Take your discussions further & build new relationships in a relaxed & informal setting
08:30 – Coffee and registration
09:30 - Chairperson opening remarks
BILL ARONSON, COO, Artificial Intelligence Research Group
SERIALISATION – TRACK & TRACE
09:40 – Benefits beyond compliance
MARCEL DE GRUTTER, Project Manager Serialization - Regulatory & Government Affairs Liaison, Abbott
10:20 – Bristol-Myers Squibb Forensics & Brand Protection – Ensuring Supply Chain Integrity and Patient Safety through Advanced Analytical Capability & Matrix Collaboration
• Scope – Who we are, What we do, Matrix teams involved, and Why?
• Technologies, Capabilities, Methodologies, and Strategies used to ensure Integrity of the Supply Chain and Patient Safety
• Case Studies – Recent examples of how Strategies and Technologies are utilized
• Future? How might Brand Protection look in a future state
JEREMY PETERS, Scientist, Bristol-Myers Squibb (USA)
11:00 – Morning Coffee & Networking
11:30 – Panel Discussion with the experts– Serialisation – Track & Trace – Making the best of it
• Identify the challenge and opportunity space for serialization and interoperability: what technology is right for you?
• The Business value of Serialization, Crossing your barriers; identify and develop your solutions
• Practical approach to implementing a serialisation solution
• Benefits/Possible Risks Beyond Serialization
• Track & Trace – The smart solution
• What are the traceability challenges still to overcome in the next 5 years?
• Opportunities as we move over the next 3-5 years
• Practical Issues for operationalising
Moderator
BILL ARONSON, COO, Artificial Intelligence Research Group
Panellists
MARCEL DE GRUTTER, Project Manager Serialization - Regulatory & Government Affairs Liaison, Abbott
SEBASTIEN MAUEL, Director of the Serialization Program, Ferring Pharmaceuticals
AREN AVADISYAN, Country Quality Head, Sanofi
JOHN SIMMONS, Serialization and Coding Quality Lead, GSK
12:10 – Holistic Supply Chain Management for sensitive Goods
• Addressing the challenges of pharma supply chain tracking from an end-to-end perspective and on article-level
• Using emerging technologies to optimize and automate supply chains
SIMON DOSSEGGER, CEO, modum.io AG
12:30 – Networking luncheon / Exhibition Visit
13:50 – Let’s get physical
• How we can use physics to defeat fakes
BILL ARONSON, COO, Artificial Intelligence Research Group
14:10 – Establishing a reliable internal network for investigations on crime against products
• Advantages of internal experts
• Importance of internal steering functions
EIKE HILLBRICHT, Corporate Security Manager, Boehringer Ingelheim
14:50 – Afternoon coffee & Networking
REGULATORY
15:20 - Counterfeit medicines - The regulatory and industry challenges
Zina Chatzidimitriadou, Counsel, Sidley Austin
15:50 – Panel Discussion: Global regulatory developments and updates
• Recent evolving regulatory frameworks - EU and US – Comparing with RoW
• Understand the coordination challenge across industry and government stakeholders
• How regulation seeks to respond to the collective coordination challenge?
• Global regulatory challenges and solutions
• How government seeks to regulate IoT and emergent technology to address the counterfeiting challenge
• A holistic strategy that includes collaboration with law enforcement authorities, regulatory officials, supply chain partners, and packaging technology specialists
• What governments expect from brand holders and pharmaceutical stakeholders?
Moderator
BILL ARONSON, COO, Artificial Intelligence Research Group
Panellists
MATTHEW COPE, Deputy Director, IP Enforcement, Intellectual Property Office
Zina Chatzidimitriadou, Counsel, Sidley Austin
16:20 - Chairperson’s closing remarks and end of conference
Share
Now
Event Sponsors & Partners
Virtue Insight
CONCEPTUALISED BY
Virtue Insight
CONCEPTUALISED BY
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
Testimonials
WCO IPM Manager
Food And Drugs Authority, Ghana Head, Market Surveillance Unit
Element Six Business Development Manager
Bayer Consumer Care AG Head Global Packaging Management
horus security Horus Security Consultancy
Selcia ltd Business Development Director
Novartis International Product Security Analyst
QPQuandary CEO
AstraZeneca Plc Regional Investigations Director EMEA, Global Security
Food And Drugs Authority, Ghana Regulatory Officer ( Safe Disposal of Regulated Products)
Gallery
Get Involved
Speaking Opportunities
Fen Castro
fen@virtueinsight.co.in
+91 44 42108101
Sponsor / Exhibit / Delegate Bookings
Piyush Patel
piyush@virtueinsightevents.com
+44 20 3509 3779
